These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 26417634)
1. Parkinson's disease: initial treatment of motor disorders. Prescrire Int; 2015 Sep; 24(163):215-7. PubMed ID: 26417634 [TBL] [Abstract][Full Text] [Related]
2. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study. Im JH; Ha JH; Cho IS; Lee MC J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999 [TBL] [Abstract][Full Text] [Related]
3. Ropinirole: new preparation. Wait for more convincing data. Prescrire Int; 1998 Apr; 7(34):36-8. PubMed ID: 10183378 [TBL] [Abstract][Full Text] [Related]
4. Ropinirole as compared with levodopa in Parkinson's disease. Hiner BC; Earnhart M N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001684 [No Abstract] [Full Text] [Related]
5. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. Rascol O; Brooks DJ; Korczyn AD; De Deyn PP; Clarke CE; Lang AE N Engl J Med; 2000 May; 342(20):1484-91. PubMed ID: 10816186 [TBL] [Abstract][Full Text] [Related]
6. Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease. Rascol O; Lees AJ; Senard JM; Pirtosek Z; Montastruc JL; Fuell D Clin Neuropharmacol; 1996 Jun; 19(3):234-45. PubMed ID: 8726542 [TBL] [Abstract][Full Text] [Related]
7. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339 [TBL] [Abstract][Full Text] [Related]
8. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life. Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551 [TBL] [Abstract][Full Text] [Related]
9. Clinical inquiry. Which drugs work best for early Parkinson's disease? Jain L; Benko R; Safranek S J Fam Pract; 2012 Feb; 61(2):106-8. PubMed ID: 22312616 [TBL] [Abstract][Full Text] [Related]
10. Levodopa-related motor complications--phenomenology. Fox SH; Lang AE Mov Disord; 2008; 23 Suppl 3():S509-14. PubMed ID: 18781677 [TBL] [Abstract][Full Text] [Related]
11. Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Mizuno Y; Abe T; Hasegawa K; Kuno S; Kondo T; Yamamoto M; Nakashima M; Kanazawa I; Mov Disord; 2007 Oct; 22(13):1860-5. PubMed ID: 17618525 [TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients. Rascol O; Lees AJ; Senard JM; Pirtosek Z; Brefel C; Montastruc JL; Fuell D Adv Neurol; 1996; 69():531-4. PubMed ID: 8615176 [No Abstract] [Full Text] [Related]
14. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029 [TBL] [Abstract][Full Text] [Related]
15. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy]. Buchwald B; Angersbach D; Jost WH Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044 [TBL] [Abstract][Full Text] [Related]
17. Ropinirole in the symptomatic treatment of Parkinson's disease. Brooks DJ; Torjanski N; Burn DJ J Neural Transm Suppl; 1995; 45():231-8. PubMed ID: 8748630 [TBL] [Abstract][Full Text] [Related]
18. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. McColl CD; Reardon KA; Shiff M; Kempster PA Mov Disord; 2002 Nov; 17(6):1227-34. PubMed ID: 12465061 [TBL] [Abstract][Full Text] [Related]